WW 277
Pill imprint WW 277 has been identified as Lithium carbonate extended release 450 mg.
Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania; cluster headaches and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy.
Lithium 450 mg is not subject to the Controlled Substances Act.
See also related documents.
Lithium carbonate extended release Images
- Imprint:
-
WW 277
- Strength:
- 450 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- ferric oxide yellow
corn starch
alginic acid
povidone
magnesium stearate
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- 00143-1277
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-6204 | Major Pharmaceuticals |
| 68084-0043 | Amerisource Health Services |
| 35356-0506 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Lithium Carbonate Extended Release resources
- Lithium
- Lithium (Wolters Kluwer)
- Lithium Controlled-Release and Extended-Release Tablets (Wolters Kluwer)
- Lithium Syrup (Wolters Kluwer)
- lithium (Cerner Multum)
- lithium (Micromedex) - Includes Dosage Information
- Lithium Salts (AHFS DI)
- Lithane (FDA)
- Lithium (FDA)
- Lithium Capsules (FDA)
- Lithium Carbonate (FDA)
- Lithium Carbonate Tablets (FDA)
- Lithium Citrate Syrup (FDA)
- Lithium ER (FDA)
- Lithium Oral Solution (FDA)
- Lithium (Wolters Kluwer)
Search Again
